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Implication for health policy/practice/research/medical education:
In a study on 36 hemodialysis patients, we observed a positive correlation between serum leptin level and body mass index and hemoglobin, 
which supports the theory of a reverse epidemiological role for leptin in regular hemodialysis patients.
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To examine the association of serum leptin level with anemia in hemodialysis, we investigated 36 patients 
(males: 21, diabetics: 11) under regular hemodialysis. For patients, complete blood counts, iron profile, 
serum leptin, and adequacy of hemodialysis were assessed. In this study a significant correlation of serum 
leptin with level of hemoglobin and body mass index was detected. An association between serum leptin 
and total iron binding capacity was observed. No correlation of serum ferritin with leptin level was seen. 
Our findings attest previous findings showing that greater serum leptin levels are associated with greater 
hemoglobin levels.
Introduction   
Recent investigations have shown that leptin is cleared 
principally by the kidney. Therefore, serum leptin concentrations 
are increased in patients with chronic kidney disease and those 
undergoing maintenance dialysis (1-3). It has been thought 
that high serum leptin level may contribute to uremic anorexia 
and malnutrition (3-5). Serum leptin is generally elevated in 
chronic kidney disease and hemodialysis. Recent studies in 
dialysis patients suggest a paradoxically inverse relationship 
between elevated serum leptin and markers of nutritional 
status, a finding that is consistent with the theory of reverse 
epidemiology (2-8). 
Usually chronic kidney disease patients develop anemia, which 
predominantly due to insufficient erythropoietin production 
by kidneys (9). Recently, studies have suggested a role for leptin 
in early stage of erythropoiesis and leptin has been found to 
stimulate hematopoietic stem cells in vitro (6-11). 
Objectives
Studies regarding the association of serum leptin with anemia 
in regular hemodialysis patients are quiet scarce. The aim of this 
study was to determine whether hyperleptinemia correlated 
with anemia markers in hemodialysis patients.
Patients and Methods   
This cross-sectional study was conducted on stable hemodialysis 
patients. We excluded patients who had active or chronic 
infection, and those using non-steroidal anti-inflammatory 
drugs (NSAID) or angiotensin converting enzyme (ACE) 
inhibitors.
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Laboratory assessments
Complete blood counts, serum iron, total iron binding capacity 
(TIBC), serum ferritin, serum creatinine, pre and post-dialysis 
blood urea nitrogen (BUN) was assessed. Blood samples were 
drawn after an overnight fast. Serum Leptin (normal range of 
values for males is 3.84 (1.79) and for females is 7.36 (3.73) ng/
ml) was measured by enzyme-linked immunosorbent assay 
(ELISA) method using DRG kits- Germany.
To evaluate the efficacy of hemodialysis, the urea reduction rate 
(URR) was calculated from pre- and post-blood urea nitrogen 
(BUN) data (12). Body mass index (BMI) was calculated 
using the standard formula (post dialysis weight in kilograms/
height in square meters; kg/m2) (13). Duration of hemodialysis 
treatment were obtained from the patients’ records. The 
duration of each hemodialysis session was 4 hours.
Ethical approval
All patients signed the consent form for participation in this 
study. Research study was approved by the ethics committee of 
Shahrekord University of Medical Sciences, Iran.
Statistical Analysis   
Statistical analysis was performed on total hemodialysis 
(HD), females, males, diabetic and non-diabetic populations 
separately. Data were expressed as the mean ± standard 
deviation (SD). Student’s t-test was used to compare the study 
groups. Partial correlation and Pearson tests were used to 
evaluate statistical correlations. All statistical analyses were 
performed using SPSS (version 11.5). Statistical significance 
was determined at a p-value<0.05.
Results   
There was 36 hemodialysis patients (15 females, 21 males) 
consisting of 25 (11 females, 14 males) non-diabetic patients 
and 11 (4 females, 7 males) diabetic hemodialysis patients. 
Table 1, shows the patients’ data. The mean patients’ age was 
47 (17) years. The median value of serum leptin in the study 
patients was 5.75 ng/ml; the median values of serum leptin 
in the diabetic and non-diabetic groups were 8.3 and 4 ng/
ml, respectively. There was a significant positive correlation 
of serum leptin with hemoglobin levels (r= 0.36, p= 0.033). A 
significant positive correlation of serum leptin with BMI (r= 
0.56, p< 0.001). There was no significant correlation between 
serum leptin and serum ferritin or total iron binding capacity 
in all patients or in the subgroups.
Discussion   
In this study, we found a significant positive correlation 
between serum leptin and hemoglobin and body mass index. 
Tungtrongchitr et al, considered, 214 overweight patients 
without kidney failure (body mass index ≥25). They found 
a significantly higher serum leptin level, mean corpuscular 
hemoglobin concentration and mean corpuscular volume in the 
overweights, in comparison to the control subjects (14). Previous 
studies in hemodialysis patients indicated that individuals with 
high serum leptin levels were more likely to lose weight (15-17). 
However, more recent studies of hemodialysis patients suggest 
a paradoxically inverse association between higher serum 
leptin and markers of nutritional status (6,7), a finding that was 
consistent with the theory of reverse epidemiology (8). Leptin 
is similar to serum albumin, which is a negative acute phase 
reactant in end-stage kidney failure patients (7).
A study conducted by Dedoussis et al. on 40 beta-thalassemia 
patients found that leptin might play some role in hematopoiesis 
(18). Kokot et al. assessed the influence of 12 months of Eprex 
therapy on plasma leptin in 15 hemodialysis patients and 
showed significantly lower leptin level after 3, 6, and 12 months 
of Eprex therapy as compared to the beginning of the study 
(19).
Of interest, hemodialysis patients with a high body mass index 
Table 1. Patients’ data
Patients 
N=36 Minimum Maximum Mean±SD Median
Age ( year) 16 80 47±17 43
DH* ( month) 2 156 32±36 19
Dialysis sessions 36 1584 294±393 156
URR ( %) 39 76 59±9 57.5
Leptin (ng/ml) 0.10 73 9.4±14 5.75
Hgb (g/dl) 5 13 9±2 9
HCT (%) 14 40 28±6 2905
Ferritin(ng/dl) 35 1250 519±299 426
Iron (micg/dl) 10 1515 350±454 69
TIBC (micg/dl) 200 1875 968±562 1059
BMI (kg/m2) 16 34 21.8±4.5 21.5
*Duration of hemodialysis treatment
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are less likely to experience severe anemia (20,21). Takeda et 
al. examined patients who could maintain high hemoglobin 
levels without the use of Eprex and found that in long-term 
hemodialysis patients, serum leptin levels correlated inversely 
with Eprex dose (22). Stenvinkel et al. also found that weekly 
Eprex doses correlated negatively with both body fat mass and 
serum leptin levels in patients with end-stage kidney failure 
not yet receiving dialysis (23). Hung et al. imagined that 
increasing caloric intake, body fat mass and leptin levels may 
enhance erythropoiesis in long-term hemodialysis patients. 
Hyperleptinemia may reflect better nutritional status and Eprex 
response in hemodialysis patients. Increasing energy intake 
corrects erythropoiesis, which may be partly mediated by an 
increase in serum leptin levels (24). Increased leptin levels 
could both improve the erythropoietic response and reduce 
Eprex dose when greater body fat mass is achieved by caloric 
supplementation (24). While, leptin is considered an “appetite 
inhibitor” in the general population, its role in end-stage kidney 
failure patients is somewhat unconventional. Serum leptin is 
generally elevated in end-stage kidney failure patients, but this 
has not been observed in anorexia. Leptin has been shown to 
act synergistically with erythropoietin to stimulate end-stage 
colony-forming-unit erythroid in humans (25). 
Conclusion
In this study, we detected a positive correlation between serum 
leptin level with body mass index and hemoglobin level, which 
supports the theory of a reverse epidemiological role for leptin 
in the regular hemodialysis patients.
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